We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Circulating Exosomes Analysis Uses Microfluidic Technology

By LabMedica International staff writers
Posted on 23 Oct 2014
Print article
Image: The prototype polydimethylsiloxane (PDMS) chip containing a cascading microchannel network for multi-stage exosome analysis (Photo courtesy of the University of Kansas).
Image: The prototype polydimethylsiloxane (PDMS) chip containing a cascading microchannel network for multi-stage exosome analysis (Photo courtesy of the University of Kansas).
A new microfluidic approach has been developed to streamline and expedite the exosome analysis pipeline by integrating specific immunoisolation and targeted protein analysis of circulating exosomes.

Tumor-derived exosomes have attracted increasing interest in non-invasive cancer diagnosis and monitoring of treatment response which will help in developing blood-based tests for disease diagnosis, especially when biopsy is difficult, costly, and sometimes not even an option.

Scientists and bioengineers at the University of Kansas Medical Center (Kansas City, KS, USA) devised an approach that enables selective subpopulation isolation and quantitative detection of surface and intravesicular biomarkers. This can be done directly from a minimally invasive amount of plasma samples, within about 100 minutes with markedly improved detection sensitivity. The microfluidic technology uses a magnetic bead-based strategy to integrate and streamline the multi-step analysis of exosomes directly from human plasma. Compared to the surface-based exosome microchips the immunomagnetic method allows for enrichment of captured exosomes and convenient sample preparation for transmission electron microscopy (TEM) characterization in addition to higher capture efficiency and analysis sensitivity due to the larger surface area.

The scientists applied the technology to analyze clinical plasma specimens, mainly from non-small-cell lung cancer (NSCLC) patients. The prototype lab-on-a-chip is made of a widely used silicone rubber called polydimethylsiloxane and uses a technique called "on-chip immunoisolation”. To demonstrate the ability to detect exosomal expression patterns associated with cancer, the team conducted relative quantification of five exosome subpopulations defined by individual surface markers using TEM. They optimized the on-chip bead-based immunoassay and chemifluorescence readout using a matched pair of capture/detection antibodies, an alkaline phosphatase (AP)-conjugated secondary antibody, and the 6,8-Difluoro-7-Hydroxy-4-Methylcoumarin (DiFMUP) substrate.

Yong Zeng, PhD, a co-author of the study, said, “Our technique provides a general platform to detecting tumor-derived exosomes for cancer diagnosis. In addition to lung cancer, we've also tested for ovarian cancer in this work. In theory, it should be applicable to other types of cancer. Our long-term goal is to translate this technology into clinical investigation of the pathological implication of exosomes in tumor development. Such knowledge would help develop better predictive biomarkers and more efficient targeted therapy to improve the clinical outcome.” The study was published in the October 2014 issue of the journal Lab on a Chip.

Related Links:

University of Kansas Medical Center


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.